Orange County's venture capital scene fell into a lull in the second quarter, even as funding nationwide soared to a 13-year high.

VC firms put $167 million to work in O.C. companies last quarter, almost flat with the year-earlier total. But just nine O.C. companies got funding in Q2, half the number of a year earlier, according to data firm CB Insights.

By contrast, venture capital investment hit $13.88 billion nationwide last quarter, almost double the total in the same period of 2013. The number of deals climbed 21%.

"O.C. suffered from a dearth of funding for its bread-and-butter industry, health care. Medical-device and drug firms, nurtured by UC Irvine connections, have long dominated the startup field in the county," notes Billy O'Grady, senior vice president and head of City National's Southern California Technology Group.

"The second-quarter slump may just be a temporary slowdown," O'Grady said. Although few O.C. health care firms were funded in the quarter, those on the list demonstrated the breadth of the area's medical technology.

At the top of the list: Alignment Healthcare. The Irvine company got a $125 million growth-equity commitment from investment firm General Atlantic.

Alignment is a startup company focused on helping health care providers boost efficiency as mandated by the Affordable Care Act.

The firm, formed by a group of veteran health care executives, says its know-how in technology, risk-management and other areas can improve both patient care and profitability for doctors, hospitals and payers.

No. 2 on the O.C. venture list last quarter was Sequent Medical, which got a $20 million Series D capital infusion from a VC group led by Delphi Ventures.

Sequent, launched in 2007 in Aliso Viejo, has developed new technology to treat brain aneurysms. Its devices are in use overseas, but not yet in the U.S.

The third-biggest O.C. deal was a $7.2 million Series D investment in Irvine-based Breathe Technologies. The company makes wearable devices that help patients breathe. Its CEO, Larry Mastrovich, joined in 2010 from another O.C. medical tech firm, Apria Healthcare, after Apria was bought by private equity firm Blackstone Group.

Outside the health care realm, O.C.'s PEAR Sports landed $5 million in Series A funding last quarter. The Irvine company creates apps that provide real-time coaching help and data-tracking for athletes in a wide range of sports, including running, biking and kayaking.

PEAR co-founder Kristian Rauhala previously launched H2O Audio, a designer of waterproof audio devices.


  2 Q 2014 1 Q 2014 4 Q 2013 3 Q 2013 2 Q 2013
Number of Financing Deals 9 15 11 12 18
Amount Invested ($M) $167.2 $226.5 $245.3 $128.3 $163.4


Alignment Healthcare Continuous health care IT and service provider Irvine Growth Equity $125 General Atlantic
Sequent Medical Neurovascular medical devices Aliso Viejo Series D $20 US Venture Partners, Delphi Ventures, Versant Ventures, Domain Associates
Breathe Technologies Ventilator systems provider Irvine Series D $7.2 Kleiner Perkins Caufield & Byers, Synergy Partners International
Insightra Medical Medical device technology Irvine Series D $6 Tekla Capital Management, Baird Venture Partners
PEAR Sports Smart fitness and training system Irvine Series A $5 Nordic Venture Partners, Innovate Partners, Vizio
vWise Interactive media developer Aliso Viejo Series D $1.5 Mosaik Partners
Consumer Brands Internet domain development Aliso Viejo Seed VC - II $1.4 Black Diamond Ventures
Cirro Big data analysis services Aliso Viejo Series A $1 GE Ventures


*Quarterly tallies consist of equity rounds completed in the quarter and in which a venture capital or corporate venture firm participated in the round.

The content of Venture Capital Report is compiled from data and sources believed to be reliable, but is not guaranteed as to accuracy or completeness. Opinions expressed are those of the authors or the interviewees and are not necessarily the opinions of City National Bank, member FDIC. This publication is intended to be a source of general information regarding subject matters of interest to our clients. The effectiveness of the advice or suggestions presented, if any, will depend on the reader's situation and are for the reader to determine. If investments are discussed, the discussion should not be considered or relied upon as specific investment advice directed to the reader's specific investment objectives, nor should any discussion of specific securities be taken as a solicitation or recommendation for any reader to buy or sell such securities. City National Bank (and its clients or associated persons) may at times have positions in securities and investments discussed from time to time in this publication and may make additional purchases or sales inconsistent with the discussion. City National Bank, as a matter of policy, does not give tax, accounting, regulatory or legal advice. Rules and regulations in the areas of law, tax and accounting are subject to change and open to varying interpretations. The reader is encouraged to consult his or her own tax and legal adviser.


Investment and Insurance Products: 
• Are Not insured by the FDIC or any other federal government agency 
• Are Not deposits of or guaranteed by a Bank or any Bank Affiliate 
• May Lose Value